.jpg)
.png)
Spring 2015
This issue sponsored by the Northeast Lipid Association Featuring: "Gender Differences in the Diagnosis and Treatment of the Metabolic Syndrome" and "Turner Syndrome: An Overlooked Gender-Specific Cardiovascular Risk Factor" more
Coronary heart disease (CHD) is the leading cause of death of men and women in the world but in younger age groups, the CHD-related death rate is strikingly higher in men compared to women.1 Emerging evidence suggests that a disparity exists in regards to cardiovascular risks and outcomes among the... more
Cardiovascular disease affects one in three adult males and accounts for 25 percent of their mortality, making it the leading cause of death for men in the U.S.1,2 Clinical androgen deficiency, characterized by low testosterone levels with manifest symptoms, affects a large number of middle-aged... more
It is well known that women are not protected from cardiovascular events but experience event rates at older ages equivalent to men after a 10-year lag time. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study showed similar findings regarding atherosclerosis, with 25- to 34-... more
Introduction Symptomatic coronary atherosclerosis is rare in women under age 40, even when conventional risk factors are present. This “athero-protection” has been attributed to the female “hormonal advantage” during premenopausal years. However, it has been speculated that other, non-hormonal X... more
“Tell me and I forget. Teach me and I remember. Involve me and I learn.” – Benjamin Franklin With so many topics in the medical and lay news specifically for us, it’s a great time to be a clinical lipidologist! People are talking about the expanded and nuanced role of... more
Merle Myerson, MD, is a woman of many talents and a wearer of many hats. Her dedication to her work is more of a passion than a career, and according to her, it is her “vocation and avocation.” As founder and director of the Mount Sinai Roosevelt and St. Luke’s Cardiovascular Disease... more
The Foundation of the National Lipid Association (FNLA) supports patient and clinician educational, research, and community outreach activities that enhance and support the initiatives of the NLA in its efforts to reduce cardiovascular events and deaths related to abnormalities of cholesterol... more
After a successful 2014, the National Lipid Association is poised for an even better 2015. We are consistently seeking ways to improve our educational programs and professional development opportunities. We want to continue to be the voice for Clinical Lipidology. One of the ways we do this is... more
I am greatly honored and humbled to hold the office of President of the Northeast Lipid Association (NELA). I appreciate the endorsement of this multidisciplinary organization, one in which a nurse practitioner has the opportunity to rise to the level of president. I have been a board member since... more